王健偉，1968年12月出生，籍貫山東，病毒學(xué)專家，中國醫(yī)學(xué)科學(xué)院副院長、北京協(xié)和醫(yī)學(xué)院副校長、中國醫(yī)學(xué)科學(xué)院學(xué)術(shù)咨詢委員會(huì)學(xué)部委員、教授（長聘）、研究員、博士生導(dǎo)師，克里斯托弗·梅里埃實(shí)驗(yàn)室主任。榮獲全國創(chuàng)新爭先獎(jiǎng)、全國優(yōu)秀科技工作者、全國科技系統(tǒng)抗擊新冠肺炎疫情先進(jìn)個(gè)人、吳階平-保羅﹒楊森醫(yī)學(xué)藥學(xué)獎(jiǎng)、吳階平醫(yī)藥創(chuàng)新獎(jiǎng)等榮譽(yù)和獎(jiǎng)勵(lì)。入選國家杰青、創(chuàng)新群體負(fù)責(zé)人等人才項(xiàng)目。

主要從事呼吸道病毒感染致病機(jī)制及其防控研究。

久久综合九色欧美综合狠狠_伊人热热久久原色播放WWW_成A人片亚洲日本久久_久久不见久久见免费影院www日本_97久久精品人人做人人爽,又色又爽又黄的视频在线观看,狼群影院视频在线观看高清版,亚洲AV无码精品网站性色,国产乱码久久久久久红粉影视,精品国产乱码久久久久久一区二区,国产精品免费视频网站,国产A级毛片久久久久久精品,一级特黄高清aaaa大片,亚洲中文字幕欧美一区,久久精品国产99久久狂热,黑人巨大精品欧美_黑人巨大精品欧美黑寡妇_黑人巨大精品欧美一区二区_黑人巨大精品欧美一区二区免费_黑人巨大跨种族video_黑人巨大无码中文字幕无码_黑人巨茎大战俄罗斯美女_黑人巨茎大战俄罗斯美女,中文字幕av不卡|亚洲欧美国产另类|天天干在线播放|日韩黄视频|欧美七区|可以免费看毛片的网站|黄色片在线|国产精品96久久久久久

1.Guo L; Wang G; Wang Y; Zhang Q; Ren L; Gu X; Huang T; Zhong J; Wang Y; Wang X; Huang L; Xu L; Wang C; Chen L; Xiao X; Peng Y; Knight JC; Dong T; Cao B*; Wang J*. SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study. 2022, Lancet Microbe. 3(5):e348-e356. （IF 86.208，F26）

2. Sun L#; Li P; Ju X; Rao J; Huang W; Ren L; Zhang S; Xiong T; Xu K; Zhou X; Gong M; Miska E ; Ding Q*; Wang J*; Zhang QC*. In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs., 2021, Cell. 184(7):1865-1883.e20. （IF 66.85，F77）

3. He Z#; Ren L; Yang J; Guo L; Feng L; Ma C; Wang X; Leng Z; Tong X; Zhou W; Wang G; Zhang T ; Guo Y; Wu C; Wang Q; Liu M; Wang C; Jia M; Hu X; Wang Y; Zhang X; Hu R; Zhong J; Yang J; Dai J; Chen L; Zhou X; Wang J*; Yang W*; Wang C*. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study. 2021, Lancet. 397(10279):1075-1084. （IF 202.731，F150）

4. Huang L; Yao Q; Gu X; Wang Q; Ren; Wang Y; Hu P; Guo L; Liu M; Xu J; Zhang X; Qu Y; Fan Y; Li X; Li C; Yu T; Xia J; Wei M; Chen L; Li Y; Xiao F; Liu D; Wang J*; Wang X*; Cao B*. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. 2021, Lancet. 398(10302):747-758. （IF 202.731，F341）

5.Ren L#; Wang Y; Wu Z; Xiang Z; Guo L; Xu T; Jiang Y; Xiong Y; Li Y; Li X; Li H; Fan G; Gu X; Xiao Y; Gao H; Xu J; Yang F; Wang X; Wu C; Chen L; Liu Y; Liu B; Yang J; Wang X; Dong J; Li L;Huang C; Zhao J; Hu Y; Cheng Z; Liu L; Qian Z; Qin C*; Jin Q*; Cao B*; Wang J*. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study .2020, Chin Med J.133(9):1015-1024.(（IF 6.133，F 696）

6. Huang C#; Wang Y; Li X; Ren L; Zhao J; Hu Y; Zhang L; Fan G; Xu J; Gu X; Cheng Z; Yu T; Xi a J; Wei Y; Wu W; Xie X; Yin W; Li H; Liu M; Xiao Y; Gao H; Guo L; Xie J; Wang G; Jiang R; Gao Z; Jin 1; Wang J*; Cao B*. Clinical features of patients infected with 2019 novel coronavirus in Wuhan .2020, Lancet. 395(10223):497-506.( （IF 202.731，F12574）

7. Zhou Z#; Ren L; Zhang L; Zhong J; Xiao Y; Jia Z; Guo L; Yang J; Wang C; Jiang S; Yang D; Z hang G; Li H; Chen F; Xu Y; Chen M; Gao Z; Yang J; Dong J; Liu B; Zhang X; Wang W; He K; Jin Q; Li M*; Wang J*. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients. 2020, Cell Host Microbe. 27(6):883-890. （IF 31.316，F552）

8. Han Z#; Rao J; Xie Z; Wang C; Xu B; Qian S; Wang Y; Zhu J; Yang B; Xu F; Lei X; Guo F; Zha o Z; Ren L*; Wang J*. Chemokine (C-X-C Motif) Ligand 4 Is a Restrictor of Respiratory Syncytial Virus Infection and an Indicator of Clinical Severity.2020, Am J Resp Crit Care Med. 2020(5):717-729. （IF 30.528，F9）

9. Zhou Z#; Cao M; Guo Y; Zhao L; Wang J; Jia X; Li J; Wang C; Gülsah G; Xue Q; Yi Y; Cui S; Jin Q *; Wang J*. Fragile X mental retardation protein stimulates ribonucleoprotein assembly of influenza A virus. Deng T*，2014, Nat Commun.5:3259. （IF 17.694，F32）

10. Zhou Z; Jia X; Xue Q; Dou Z; Ma Y; Zhao Z; Jiang Z; He B; Jin Q*; Wang J*. TRIM14 is a mitochondrial adaptor that facilitates retinoic acid-inducible gene-I-like receptor-mediated innate immune response. 2014, Proc Natl Acad Sci U S A. 111(2):E245-54. （IF 12.779，F96）